InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Spear Matthew A., Directeur Médical. Director active across 1 companies, notably Poseida Therapeutics, Inc.. In total, 13 reports have been recorded. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
050,000 shares0
Common Stock
SEC:0001209191-22-014373:0·
€11,69410,000 shares@ €1.169419.6% of flow
Common Stock
SEC:0001209191-21-068629·
€11,69410,000 shares@ €1.16949.8% of flow
Common Stock
SEC:0001209191-21-068629:0·
€11,17910,000 shares@ €1.117918.8% of flow
Common Stock
SEC:0001209191-21-055443·
€11,17910,000 shares@ €1.11799.4% of flow
Common Stock
SEC:0001209191-21-055443:0·
€4,5294,000 shares@ €1.13227.6% of flow
Common Stock
SEC:0001209191-21-053177·
€4,5294,000 shares@ €1.13223.8% of flow
Common Stock
SEC:0001209191-21-053177:0·
€22,32020,000 shares@ €1.11637.4% of flow
Common Stock
SEC:0001209191-21-048793·
€22,32020,000 shares@ €1.11618.7% of flow
Common Stock
SEC:0001209191-21-048793:0·
€5,5485,000 shares@ €1.10979.3% of flow
Common Stock
SEC:0001209191-21-042292·
€5,5485,000 shares@ €1.10974.7% of flow
Common Stock
SEC:0001209191-21-042292:0·
€4,3444,000 shares@ €1.0867.3% of flow
Common Stock
SEC:0001209191-21-040324·
€4,3444,000 shares@ €1.0863.6% of flow
Common Stock
SEC:0001209191-21-040324:0·
13 of 13 declarations
About Spear Matthew A.
Matthew A. Spear is the Chief Medical Officer at Poseida Therapeutics, Inc. He is responsible for the medical direction of the company, overseeing clinical research and the development of new treatments. His role is essential in ensuring innovation and safety of Poseida's products.
